A protein called PCSK9 determines how pancreatic cancer cells metastasize to different parts of the body. Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs ...
Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The spread ...
Pfizer has been working on developing an oral pill and vaccine that will target PCSK9, the protein that maintains LDL or “bad” cholesterol in the bloodstream, according to a Reuters report. The ...
Single infusion of VERVE-102 led to dose-dependent decreases in blood PCSK9 and LDL-C, with mean reduction in LDL-C of 53% and a maximum reduction of 69% observed in the 0.6 mg/kg dose cohort ...
Merck has unveiled a groundbreaking cholesterol-lowering pill, enlicitide, which could transform treatment for millions of Americans struggling with high LDL cholesterol. The once-daily oral ...
Over the past several days, two major developments have emerged in the world of cholesterol-lowering therapies—specifically concerning the heavy-hitters known as PCSK9 inhibitors. In this letter, I’d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results